Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022

Addiction(2024)10.1111/add.16652Source: DataRank Database

Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022 is a research paper published in Addiction (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.10)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Kara E. Rudolph ORCID,Chelsea L. Shover ORCID,Rachael K. Ross ORCID

Live enrichment

PubMed:39149781 PMC:PMC12050076 OpenAlex:https://openalex.org/W4401647076

National Institute on Drug Abuse

Grant: 5R01DA056407

National Institute on Drug Abuse

Grant: K01DA050771

NIDA NIH HHS

Grant: R01 DA056407

FWCI

3.10

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12050076/pdf/nihms-2077424.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/add.16652

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12050076/

journalhttps://doi.org/10.1111/add.16652

Fields of Study

Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and OutcomesMedicaidHumansBuprenorphineUnited StatesDelayed-Action PreparationsOpioid-Related DisordersOpiate Substitution TreatmentNarcotic AntagonistsDrug PrescriptionsPractice Patterns, Physicians'

MeSH Terms

BuprenorphineDelayed-Action PreparationsHumansMedicaidNarcotic AntagonistsOpioid-Related DisordersPractice Patterns, Physicians'Drug PrescriptionsUnited StatesOpiate Substitution Treatment

Keywords

MedicaidBuprenorphineMedical prescriptionOpioid use disorderMedicineFamily medicinePsychiatryEmergency medicineOpioidDemographyPharmacologyInternal medicineHealth carePolitical scienceSublocadeExtended Release BuprenorphineBrixadiInjection Buprenorphine

Sustainable Development Goals

SDG 0: Good health and well-being